오하이오의 림프종 임상 시험
림프종 관련 연구 28개가 오하이오 내 여러 지역에서 참여자를 모집하고 있습니다.
오하이오의 도시
공식 연구 텍스트(영어)
Epco, Zanu, Ritux for R/R FL or MZL
- The Ohio State University Wexner Medical Center, Columbus
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06563596Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
피험자 모집 중1상
24 Months – 18 Years · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06441331A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
- Cleveland Clinic, Cleveland
- The Ohio State University Comprehensive Cancer Center, Columbus
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07015242Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Ohio State University Comprehensive Cancer Center, Columbus
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT04301076A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
- University of Cincinnati, Cincinnati
- The Cleveland Clinic Foundation, Cleveland
- The Ohio State University, Columbus
- 외 1개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07221500Collection of Tissue Samples for Cancer Research
- Ohio State University, Columbus
피험자 모집 중관찰 연구
2 Months · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT00900198CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
피험자 모집 중1/2상
12 Months – 21 Years · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT04870944Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
- Research Site, Cleveland
피험자 모집 중3상
18세 ~ 18세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07509151A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
- University Hospitals Cleveland Medical Center, Cleveland
피험자 모집 중2상
1 Month – 17 Years · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT04570423Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- University of Cincinnati (UC) Physicians Company, LLC, Cincinnati
- Cleveland Clinic, Cleveland
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT05826535A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- University Hospitals Cleveland Medical Center, Cleveland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT07192471A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
- Cleveland Clinic, Cleveland
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT06678659A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
- University of Cincinnatti Medical Center, Cincinnatti
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT06528301Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- The Ohio State University Wexner Medical Center, Columbus
피험자 모집 중1/2상
13세 ~ 90세 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT06533579A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- Oncology Hematology Care Clinical Trials, Cincinnati
- University of Cincinnati, Cincinnati
- Cleveland Clinical Taussig Cancer Center, Cleveland
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT07188558DALY II USA/ MB-CART2019.1 for DLBCL
- The Ohio State University Wexner Medical Center James Cancer, Columbus
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 13. 업데이트됨 · NCT04792489A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
- University Hospitals Cleveland Medical Center, Cleveland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 8. 업데이트됨 · NCT07465835A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- University of Cincinnati Medical Center, Cincinnati
- Cleveland Clinic, Cleveland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 2. 업데이트됨 · NCT05131022A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
- Dren Investigational Site, Columbus
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 17. 업데이트됨 · NCT05475925Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Cincinnati Children's Hospital Medical Center, Cincinnati
피험자 모집 중관찰 연구
0세 ~ 38세 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT06131801Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 5. 18. 업데이트됨 · NCT01790152Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies
- The Ohio State University, Columbus
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 4. 24. 업데이트됨 · NCT06801002CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Cleveland Clinic, Cleveland
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 4. 16. 업데이트됨 · NCT03328078Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
- Ohio State University Comprehensive Cancer Center, Columbus
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 4. 15. 업데이트됨 · NCT07356245The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- Gabrail Cancer Center Research,, Canton
피험자 모집 중1/2상
12세 ~ 95세 · 모든 성별 · 2026. 4. 15. 업데이트됨 · NCT04329728cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Cleveland Clinic, Cleveland
피험자 모집 중관찰 연구건강한 지원자 환영
40세 이상 · 모든 성별 · 2026. 1. 20. 업데이트됨 · NCT05366881Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 11. 10. 업데이트됨 · NCT06916767HPC Offered for PRESERVE Expansion
- The Ohio State University Medical Center, Columbus
피험자 모집 중관찰 연구
12세 ~ 80세 · 모든 성별 · 2025. 8. 28. 업데이트됨 · NCT07145411ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.